Results 121 to 130 of about 1,565,191 (184)

Psychological Adverse Events and Associated Safety Profiles of Doxepin: A Pharmacovigilance Study Using VigiBase. [PDF]

J Korean Med Sci
Lee CY, Yoon D, Ha M, Lee MS, Kim YW, Lee J, Shin JY.   +6 more
europepmc   +1 more source

Repeated intranasal esketamine augmentation in treatment-resistant obsessive-compulsive disorder with comorbid major depressive disorder: a prospective case series. [PDF]

BMC Psychiatry
López-Rodríguez S, Segalàs C, Real E, Urretavizcaya M, Bertolín S, Menchón JM, Del Pino Alonso.   +6 more
europepmc   +1 more source

The Effect of Use of Tricyclic Antidepressants or Serotonin-Norepinephrine Reuptake Inhibitors Versus Selective Serotonin Reuptake Inhibitors on the Risk of Urinary Tract Infection Among People With Multiple Sclerosis: A Nested Case-Control Study. [PDF]

Pharmacoepidemiol Drug Saf
Leung MWY, van de Garde EMW, Uitdehaag BMJ, Souverein PC, Klungel OH, Bazelier MT.   +5 more
europepmc   +1 more source

Mirtazapine Versus Other Antidepressive Agents for Depression

Cochrane Database of Systematic Reviews, 2011
BACKGROUND: Mirtazapine has a unique mechanism of antidepressive action and is one of the commonly used antidepressants in clinical practice. OBJECTIVES: The aim of the present review was to assess the evidence on the efficacy and acceptability of ...
Andrea Cipriani, Rachel Churchill, Atsuo Nakagawa   +2 more
exaly   +2 more sources

The Use of Antidepressive Agents and Bone Mineral Density in Women: A Meta-Analysis

International Journal of Environmental Research and Public Health, 2018
Antidepressive agents are one of the fastest-growing classes of prescribed drugs. However, the effects of antidepressive agents on bone density are controversial.
Ulrich Schweiger, Kai G Kahl, Eva Fassbinder   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Azetidine derivatives of tricyclic antidepressant agents

Journal of Medicinal Chemistry, 1979
Tricyclic derivatives of azetidine were synthesized and screened for their potential antidepressant activity. The active series had the tricyclic ring attached to position 1 and a basic group in position 3 of the azetidine. The most interesting compounds were comparable to the reference standards for reserpine antagonism in mice, the most active being ...
P, Melloni, A, Della Torre, M, Meroni, A, Ambrosini, A C, Rossi   +4 more
openaire   +2 more sources

Tricyclic Antidepressants in Obsessive-Compulsive Disorder Antiobsessional or Antidepressant Agents?

The Journal of Nervous and Mental Disease, 1983
The response to tricyclic antidepressants of eight obsessive-compulsive patients was assessed at pretreatment and at 4, 8, and 12 weeks of treatment, with the aim of delineating differential rates of improvement, or desynchrony, between the various symptoms. Change in obsessive-compulsive symptoms paralleled change in depression and anxiety, suggesting
M, Mavissakalian, L, Michelson
openaire   +2 more sources

Antidepressants II: tricyclic agents

2002
Abstract Tricyclic antidepressants (TCA) were first synthesized in the 1940s by chemists looking for drugs to act as sedatives, antihistamines, and anti-parkinsonian drugs (Baldessarini, 1996). Use in depression was first reported in the late 1950s, and hundreds of studies have confirmed their effectiveness in adult populations.
Karl Gundersen, Barbara Geller
openaire   +1 more source

Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II

American Journal of Psychiatry, 1985
The authors explored the relationship between the antiobsessional and antidepressant effects of tricyclic drugs in primary obsessive-compulsive disorders. Study 1 consisted of a controlled 12-week trial with clomipramine (N = 7) and placebo (N = 5); study 2 analyzed the pooled data from 15 patients uniformly selected and treated with either ...
M, Mavissakalian, S M, Turner, L, Michelson, R, Jacob   +3 more
openaire   +2 more sources